Physician profile
Bryan Gaudio
NPI 1679865885
$3,998.33
in general payments reported to CMS, 2019-2025
15 companies · $16.25 in 2025
The $16.25 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,172 · 2020: $601 · 2021: $1,300 · 2022: $627 · 2023: $283 · 2025: $16.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,265.22 | 2019-2023 | |
| Viiv Healthcare Company | $1,121.51 | 2019-2023 | Dovato |
| Janssen Biotech, INC. | $393.80 | 2019-2023 | Symtuza |
| Abbott Laboratories | $339.88 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $190.38 | 2019-2023 | Pifeltro, Delstrigo, Dificid |
| Theratechnologies INC. | $160.17 | 2019-2023 | Egrifta, Trogarzo |
| Janssen Products, Lp | $154.97 | 2019-2021 | |
| Abbvie INC. | $146.58 | 2021-2025 | |
| Dynavax Technologies Corporation | $70.48 | 2019-2021 | |
| Emd Serono, INC. | $49.46 | 2019-2022 | |
| Napo Pharmaceuticals INC | $30.21 | 2019 | |
| Janssen Scientific Affairs, LLC | $27.74 | 2022 | |
| Amgen INC. | $19.15 | 2019 | |
| Antares Pharma, INC. | $14.82 | 2019 | |
| Aytu Biopharma, INC. | $13.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Gaudio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.